Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry

RENSUR5 is a large ‘real-world’ database assessing metastatic renal cell carcinoma (mRCC) treatment patterns and 5-year overall survival (OS) in Russia. Five-year OS was 8.2%. Based on results of this study, we assume that 5-year OS should be improved on novel therapies. The 5-year overall survival...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical genitourinary cancer 2017-12, Vol.15 (6), p.e1069-e1072
Hauptverfasser:	Tsimafeyeu, Ilya, Zolotareva, Tatiana, Varlamov, Sergei, Zukov, Ruslan, Petkau, Vladislav, Mazhbich, Mikhail, Statsenko, Galina, Safina, Sufia, Zaitsev, Igor, Sakaeva, Dina, Popov, Alexander, Borisov, Pavel, Vladimirova, Liubov
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - pathology Carcinoma, Renal Cell - surgery Disease-Free Survival Female Five-year OS Humans Interferons - therapeutic use Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Kidney Neoplasms - surgery Male Middle Aged Molecular Targeted Therapy mRCC Neoplasm Metastasis Registries RENSUR5 database Retrospective Studies Russia Survival Analysis Treatment Outcome Treatment patterns
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!